HUTCHMED (China) Limited (HMDCF)
OTC
Real-time Data
01:30 PM
Day's Range
2.1652 wk Range
2.16Overview - HMDCF - HUTCHMED (China) Limited
Key Statistics
Valuation
Enterprise Value
609.43M
P/E (Trailing)
‪108.00‬
Price / Sales (TTM)
‪3.41‬
Price / Book
‪1.48‬
EV / EBITDA
‪-29.70‬
Profitability
Gross Margin
‪23.08%‬
Profit Margin
‪3.25%‬
Operating Margin
‪0.31%‬
Return on Assets
‪-1.23%‬
Return on Equity
‪1.46%‬
Ownership
Shares Outstanding
859.74M
Float
522.93M
Held by Insiders
‪38.79%‬
Held by Institutions
‪19.43%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪2.16‬
200-Day Avg
‪2.81‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - HMDCF - HUTCHMED (China) Limited
Peers - HMDCF - HUTCHMED (China) Limited
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- HMDCFOTCHUTCHMED (China) Limited1.87BMarket Cap-48.38%52-week change108.00P/E (Trailing)‪3.25%‬Profit Margin
- MKGAFOTCMerck KGaA70.96BMarket Cap+22.06%52-week change23.97P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR70.08BMarket Cap+20.60%52-week change23.88P/E (Trailing)‪11.21%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.66.37BMarket Cap+15.20%52-week change58.82P/E (Trailing)‪86.20%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR49.85BMarket Cap+20.44%52-week change58.64P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG47.80BMarket Cap+25.78%52-week change66.16P/E (Trailing)‪14.57%‬Profit Margin
- HLNCFOTCHaleon plc42.44BMarket Cap-1.14%52-week change19.24P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - HMDCF - HUTCHMED (China) Limited
About
HUTCHMED (China) Limited is an innovative, commercial-stage biopharmaceutical company headquartered in Hong Kong, focused on the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. Established over two decades ago as one of China's first…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
